CUAJ June 2022: A single-center, multidisciplinary experience with radium-223 dichloride in men with metastatic castrate-resistant prostate cancer
CUAJ June 2022: A single-center, multidisciplinary experience with radium-223 dichloride in men with metastatic castrate-resistant prostate cancer
Instructions:
- Click on the article image below to review the material.
- Select the start button below to begin the quiz.
- Complete the quiz and receive your Section 3 certificate of participation at the end.
Accreditation Statement
This program is an Accredited Self-Assessment Program (Section 3) as defined by the Maintenance of Certification Program of The Royal College of Physicians & Surgeons of Canada, and approved by the Canadian Urological Association. You may claim a maximum of 1 hour of credit.